Monotherapy with the vitamin D3 analogue MC1288 does not result in prolonged kidney allograft survival in rhesus monkeys

Transplant International

Volumn 19, Issue 5, 2006, Pages 396-403

  Vierboom, Michel ^a   Johnsson, C ^b   Hart, Bert 't ^a   Jonker, Margreet ^a  

^a BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Immunosuppression; Kidney transplantation; Vitamin D

Indexed keywords

20 EPICALCITRIOL; AMOXICILLIN PLUS CLAVULANIC ACID; BUPRENORPHINE; COLECALCIFEROL DERIVATIVE; GAMMA INTERFERON; IMMUNOMODULATING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; BONE METABOLISM; CALCIUM METABOLISM; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; GRAFT SURVIVAL; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; VALIDATION PROCESS;

ANIMALS; CALCITRIOL; CALCIUM; CALCIUM CHANNEL AGONISTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LYMPHOCYTES; MACACA MULATTA; MALE; MAXIMUM TOLERATED DOSE; TIME FACTORS; VITAMIN D;

EID: 33646005512     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2006.00299.x     Document Type: Article

References (27)

1. Denton MD Magee CC Sayegh MH. Immunosuppressive strategies in transplantation. Lancet 1999 353 1083.
2. Fishman JA Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998 338 1741.
3. Penn I. Post-transplant malignancy: the role of immunosuppression. Drug Saf 2000 23 101.
4. Adorini L. 1,25-Dihydroxyvitamin D3 analogs as potential therapies in transplantation. Curr Opin Investig Drugs 2002 Oct 3 1458.
5. Adorini L. Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases. Int Immunopharmacol 2002 Jun 2 1017.
6. Lemire JM Adams JS Kermani-Arab V Bakke AC Sakai R Jordan SC. 1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro. J Immunol 1985 May 134 3032.
7. Bhalla AK Amento EP Serog B Glimcher LH. 1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation. J Immunol 1984 133 1748.
8. Penna G Adorini L. 1α,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 2000 164 2405.
9. Piemonti L Monti P Sironi M Fraticelli P Leone BE Dal Cin E et al. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol 2000 May 1 164 4443.
10. Suki WN Rose D. Renal transport of calcium, magnesium and phosphate. In Brenner BM ed. The Kidney. Philadelphia Saunders 1996 472. q2
11. Brown AJ. Therapeutic uses of vitamin D analogues. Am J Kidney Dis 2001 Nov 38 5 Suppl 5 S3.
12. Binderup L Latini S Binderup E Bretting C Calverley M Hansen K. 20-epi-vitamin D3 analogues: a novel class of potent regulators of cell growth and immune responses. Biochem Pharmacol 1991 42 1569.
13. Kallio E Hayry P Pakkala S. MC1288, a vitamin D analogue, reduces short- and long-term renal allograft rejection in the rat. Transplant Proc 1996 Dec 28 3113.
14. Johnsson C Tufveson G. MC1288 - a vitamin D analogue with immunosuppressive effects on heart and small bowel grafts. Transpl Int 1994 7 392.
15. Raisanen-Sokolowski AK Pakkala IS Samila SP Binderup L Hayry PJ Pakkala ST. A vitamin D analog, MC1288, inhibits adventitial inflammation and suppresses intimal lesions in rat aortic allografts. Transplantation 1997 Apr 15 63 936.
16. Raisanen-Sokolowski A Pakkala I Vuoristo P Samila S Binderup L Hayry P et al. Effect of MC1288, a vitamin D analogue, on lymphocyte proliferation in vitro and rat aortic allograft arteriosclerosis in vivo. Transplant Proc 1996 Apr 28 919.
17. Sachs DH. Tolerance: of mice and men. J Clin Invest 2003 Jun 111 1819.
18. 't Hart B Amor S Jonker M. Evaluating the validity of animal models for research into therapies for immune-based disorders. Drug Discov Today 2004 Jun 9 517.
19. Neuhaus P Neuhaus R Wiersema HD Borleffs JC Balner H. The technique of kidney transplantation in rhesus monkeys. J Med Primatol 1982 11 155.
20. Johnsson C Binderup L Tufveson G. The effects of combined treatment with the novel vitamin D analogue MC1288 and cyclosporine A on cardiac allograft survival. Transpl Immunol 1995 Sep 3 245.
21. Thomas MK Lloyd-Jones DM Thadhani RI Shaw AC Deraska DJ Kitch BT et al. Hypovitaminosis D in medical inpatients. N Engl J Med 1998 338 777.
22. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 2004 Dec 80 1678S.
23. Hullett DA Laeseke PF Malin G Nessel R Sollinger HW Becker BN. Prevention of chronic allograft nephropathy with vitamin D. Transpl Int 2005 Oct 18 1175.
24. Gregori S Casorati M Amuchastegui S Smiroldo S Davalli AM Adorini L. Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol 2001 Aug 15 167 1945.
25. Graca L Thompson S Lin CY Adams E Cobbold SP Waldmann H. Both CD4(+)CD25(+) and CD4(+)CD25(-) regulatory cells mediate dominant transplantation tolerance. J Immunol 2002 168 5558.
26. Steinman RM Mellman I. Immunotherapy: bewitched, bothered, and bewildered no more. Science 2004 Jul 9 305 197.
27. Wiendl H Hohlfeld R. Therapeutic approaches in multiple sclerosis: lessons from failed and interrupted treatment trials. Bio Drugs 2002 16 183.